XOMAP Q4 2018 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-68.5% YoY

Gross Profit

$1M85.9% margin

Operating Income

-$3M-203.1% margin

Net Income

-$3M-178.8% margin

EPS (Diluted)

$-0.27

QoQ Revenue Growth

+88.1%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$869,000

Balance Sheet

Total Assets

$64M

Total Liabilities

$45M

Stockholders' Equity

$19M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$5M	-68.5%
Gross Profit	$1M	$5M	-69.2%
Operating Income	-$3M	-$2M	-70.2%
Net Income	-$3M	-$1M	-128.5%